CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech - Reuters

Reuters | Aug. 8, 2025, 3:51 a.m. | Original
CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech Reuters
US gold futures hit record high after report of US tariffs on gold bars - Reuters World food prices rise to two-year high in July, FAO says - Reuters